Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity treatments improve.
Novo Nordisk’s stock is rallying
· 4d · on MSN
Why Novo Nordisk Stock Popped on Friday
Novo Nordisk’s stock is rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.
Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer.
· 8h
Novo Nordisk Stock Rallies on Weight-Loss Retreat by Hims & Hers
The shortage of Novo Nordisk’s (NVO) blockbuster weight loss drugs has been resolved, according to the U.S. Food and Drug Administration
Compounded GLP-1s have become more widespread, but are they safe? Some argue that compounding is nothing new, while others believe these drugs are dangerous for patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback